EP Patent

EP4331607B1 — Solid pharmaceutical composition containing 2-{4-[n-(5,6-diphenylpyrazin-2-yl)-n-isopropylamino]butyloxy}-n-(methylsulfonyl)acetamide

Assigned to Nippon Shinyaku Co Ltd · Expires 2025-04-30 · 1y expired

What this patent protects

Patent listed against Uptravi.

Drugs covered by this patent

Patent Metadata

Patent number
EP4331607B1
Jurisdiction
EP
Classification
—
Expires
2025-04-30
Drug substance claim
No
Drug product claim
No
Assignee
Nippon Shinyaku Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.